OA03.04 Efficacy and Safety of the Novel HER3 Directed Antibody Drug Conjugate Patritumab Deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC

Authors :: Conor Steuer
Christina S Baik
Helena Alexandra Yu
W. Su
Melissa Lynne Johnson
Yang Qiu
Hidetoshi Hayashi
S. Karam
Z. Qi
Makoto Nishio
Sixue Chen
Marianna Koczywas
Kathryn A. Gold
J.C.-H. Yang
Haruyasu Murakami
C. Yu
Pasi A. Jänne
Source :: Journal of Thoracic Oncology. 16:S107
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Patritumab
Antibody-drug conjugate
Oncology
business.industry
Cancer research
Medicine
business

Full Text Access

Tools